A citation-based method for searching scientific literature

Anand A Patel, Joseph Thomas, Alexandra E Rojek, Wendy Stock. Curr Treat Options Oncol 2020
Times Cited: 7







List of co-cited articles
26 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.
Diego Sánchez-Martínez, Matteo L Baroni, Francisco Gutierrez-Agüera, Heleia Roca-Ho, Oscar Blanch-Lombarte, Sara González-García, Montserrat Torrebadell, Jordi Junca, Manuel Ramírez-Orellana, Talía Velasco-Hernández,[...]. Blood 2019
49
42

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Karen L Bride, Tiffaney L Vincent, Soo-Yeon Im, Richard Aplenc, David M Barrett, William L Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P Dunsmore,[...]. Blood 2018
97
42

Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.
Yishai Ofran, Shimrit Ringelstein-Harlev, Ilana Slouzkey, Tsila Zuckerman, Dana Yehudai-Ofir, Israel Henig, Ofrat Beyar-Katz, Michal Hayun, Avraham Frisch. Leukemia 2020
32
42

Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, Elias Jabbour, Nitin Jain, Deborah Thomas, Tapan Kadia, Gautam Borthakur, Joseph D Khoury, Jan Burger,[...]. Am J Hematol 2018
43
42

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Daniel J DeAngelo, Daohai Yu, Jeffrey L Johnson, Steven E Coutre, Richard M Stone, Alison T Stopeck, Jon P Gockerman, Beverly S Mitchell, Frederick R Appelbaum, Richard A Larson. Blood 2007
180
42

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Stacey L Berg, Susan M Blaney, Meenakshi Devidas, Tom A Lampkin, Anthony Murgo, Mark Bernstein, Amy Billett, Joanne Kurtzberg, Greg Reaman, Paul Gaynon,[...]. J Clin Oncol 2005
194
42

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Nicola Gökbuget, Nadezda Basara, Herrad Baurmann, Joachim Beck, Monika Brüggemann, Helmut Diedrich, Björn Güldenzoph, Gernot Hartung, Heinz-August Horst, Andreas Hüttmann,[...]. Blood 2011
112
42

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.
Kimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, Brent L Wood, Natia Esiashvili, Zhiguo Chen, Nancy Eisenberg, Nikki Briegel, Robert J Hayashi, Julie M Gastier-Foster,[...]. J Clin Oncol 2020
51
42


Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia.
Amélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, Francesca Rocchetti, Benedetta Zaniboni, Mohamed Belhocine, Cindy Da Costa de Jesus, Ludovic Lhermitte, Melania Tesio, Michael Dussiot,[...]. Cancer Discov 2016
27
28

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
David I Marks, Elisabeth M Paietta, Anthony V Moorman, Susan M Richards, Georgina Buck, Gordon DeWald, Adolfo Ferrando, Adele K Fielding, Anthony H Goldstone, Rhett P Ketterling,[...]. Blood 2009
233
28

Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
Bing Chen, Lu Jiang, Meng-Ling Zhong, Jian-Feng Li, Ben-Shang Li, Li-Jun Peng, Yu-Ting Dai, Bo-Wen Cui, Tian-Qi Yan, Wei-Na Zhang,[...]. Proc Natl Acad Sci U S A 2018
68
28


The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Jinghui Zhang, Li Ding, Linda Holmfeldt, Gang Wu, Sue L Heatley, Debbie Payne-Turner, John Easton, Xiang Chen, Jianmin Wang, Michael Rusch,[...]. Nature 2012
28

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Adolfo A Ferrando, Donna S Neuberg, Jane Staunton, Mignon L Loh, Christine Huard, Susana C Raimondi, Fred G Behm, Ching Hon Pui, James R Downing, D Gary Gilliland,[...]. Cancer Cell 2002
789
28

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
Yu Liu, John Easton, Ying Shao, Jamie Maciaszek, Zhaoming Wang, Mark R Wilkinson, Kelly McCastlain, Michael Edmonson, Stanley B Pounds, Lei Shi,[...]. Nat Genet 2017
423
28

CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
Lauren A Pitt, Anastasia N Tikhonova, Hai Hu, Thomas Trimarchi, Bryan King, Yixiao Gong, Marta Sanchez-Martin, Aris Tsirigos, Dan R Littman, Adolfo A Ferrando,[...]. Cancer Cell 2015
168
28

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.
Matthew L Cooper, Jaebok Choi, Karl Staser, Julie K Ritchey, Jessica M Devenport, Kayla Eckardt, Michael P Rettig, Bing Wang, Linda G Eissenberg, Armin Ghobadi,[...]. Leukemia 2018
168
28

Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients.
Jordy C G van der Zwet, Valentina Cordo', Kirsten Canté-Barrett, Jules P P Meijerink. Adv Biol Regul 2019
10
28

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.
Diogo Gomes-Silva, Madhuwanti Srinivasan, Sandhya Sharma, Ciaran M Lee, Dimitrios L Wagner, Timothy H Davis, Rayne H Rouce, Gang Bao, Malcolm K Brenner, Maksim Mamonkin. Blood 2017
179
28

A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.
Maksim Mamonkin, Rayne H Rouce, Haruko Tashiro, Malcolm K Brenner. Blood 2015
155
28

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Elaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, Frederick G Behm, Susana C Raimondi, Deqing Pei, Cheng Cheng, Xiaoping Su, Jeffrey E Rubnitz, Giuseppe Basso,[...]. Lancet Oncol 2009
571
28

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Kathryn Evans, JianXin Duan, Tara Pritchard, Connor D Jones, Lisa McDermott, Zhaohui Gu, Cara E Toscan, Narimanne El-Zein, Chelsea Mayoh, Stephen W Erickson,[...]. Clin Cancer Res 2019
13
28

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Annalisa Lonetti, Alessandra Cappellini, Alice Bertaina, Franco Locatelli, Andrea Pession, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, Laura Zambonin,[...]. J Hematol Oncol 2016
29
28

Relapsed T Cell ALL: Current Approaches and New Directions.
Christine M McMahon, Selina M Luger. Curr Hematol Malig Rep 2019
28
28

Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
C Simioni, L M Neri, G Tabellini, F Ricci, D Bressanin, F Chiarini, C Evangelisti, A Cani, P L Tazzari, F Melchionda,[...]. Leukemia 2012
59
28

Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.
A E Frankel, S L Zuckero, A A Mankin, M Grable, K Mitchell, Y J Lee, D M Neville, J H Woo. Curr Drug Targets 2009
33
14

Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia.
C H Pui, F G Behm, B Singh, M J Schell, D L Williams, G K Rivera, D K Kalwinsky, J T Sandlund, W M Crist, S C Raimondi. Blood 1990
135
14


DJ-1 protein regulates CD3+ T cell migration via overexpression of CXCR4 receptor.
Seung Hyo Jung, Kyung Jong Won, Kang Pa Lee, Dong Hyun Lee, Suyeol Yu, Dong-Youb Lee, Eun-Hye Seo, Hyun Kang, Eun-Seok Park, Hyun-Joong Kim,[...]. Atherosclerosis 2014
19
14

Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
Shan Chung, Yuwen L Lin, Chae Reed, Carl Ng, Zhijie Jey Cheng, Fabio Malavasi, Jihong Yang, Valerie Quarmby, An Song. J Immunol Methods 2014
33
14

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
Philip Went, Claudio Agostinelli, Andrea Gallamini, Pier Paolo Piccaluga, Stefano Ascani, Elena Sabattini, Francesco Bacci, Brunangelo Falini, Teresio Motta, Marco Paulli,[...]. J Clin Oncol 2006
248
14

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.
K H Chen, M Wada, K G Pinz, H Liu, K-W Lin, A Jares, A E Firor, X Shuai, H Salman, M Golightly,[...]. Leukemia 2017
91
14

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Carlos A Ramos, Brandon Ballard, Huimin Zhang, Olga Dakhova, Adrian P Gee, Zhuyong Mei, Mrinalini Bilgi, Meng-Fen Wu, Hao Liu, Bambi Grilley,[...]. J Clin Invest 2017
202
14


Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.
Pieter Van Vlierberghe, Alberto Ambesi-Impiombato, Kim De Keersmaecker, Michael Hadler, Elisabeth Paietta, Martin S Tallman, Jacob M Rowe, Carles Forne, Montserrat Rue, Adolfo A Ferrando. Blood 2013
105
14

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.
Kevin H Chen, Masayuki Wada, Amelia E Firor, Kevin G Pinz, Alexander Jares, Hua Liu, Huda Salman, Marc Golightly, Fengshuo Lan, Xun Jiang,[...]. Oncotarget 2016
65
14

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
T Nagasawa, S Hirota, K Tachibana, N Takakura, S Nishikawa, Y Kitamura, N Yoshida, H Kikutani, T Kishimoto. Nature 1996
14

A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
Martina Bamberger, Ana Mafalda Santos, Carine M Gonçalves, Marta I Oliveira, John R James, Alexandra Moreira, Franscisco Lozano, Simon J Davis, Alexandre M Carmo. J Biol Chem 2011
31
14


Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
Pieter Van Vlierberghe, Rob Pieters, H Berna Beverloo, Jules P P Meijerink. Br J Haematol 2008
106
14

Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
John M Goldberg, Lewis B Silverman, Donna E Levy, Virginia Kimball Dalton, Richard D Gelber, Leslie Lehmann, Harvey J Cohen, Stephen E Sallan, Barbara L Asselin. J Clin Oncol 2003
221
14



Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Michaela Kuhlen, Kirsten Bleckmann, Anja Möricke, Martin Schrappe, Simon Vieth, Gabriele Escherich, Annika Bronsema, Annika Vonalt, Manon Queudeville, C Michel Zwaan,[...]. Br J Haematol 2017
15
14

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma.
Herbert Riechelmann, Alexander Sauter, Wolfram Golze, Gertraud Hanft, Carsten Schroen, Karl Hoermann, Thomas Erhardt, Silke Gronau. Oral Oncol 2008
111
14

Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.
M Eder, O G Ottmann, T E Hansen-Hagge, C R Bartram, S Gillis, D Hoelzer, A Ganser. Leukemia 1990
58
14

Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
Chantal Kuhn, Howard L Weiner. Immunotherapy 2016
83
14

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies.
Masayuki Wada, Hongyu Zhang, Liu Fang, Jia Feng, Charlotte Olivia Tse, Wenli Zhang, Qi Chen, Sha Sha, Yuanzhen Cao, Kevin H Chen,[...]. Stem Cell Rev Rep 2020
6
16

Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
Vijaya Pooja Vaikari, Yang Du, Sharon Wu, Tian Zhang, Klaus Metzeler, Aarif M N Batcha, Tobias Herold, Wolfgang Hiddemann, Mojtaba Akhtari, Houda Alachkar. Haematologica 2020
10
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.